Was this Number 2 a joke or a genuine possibility? Thinking about the ADA adding Vascepa to their SOC, this seem plausible. I am just confused as to why the FDA would not be more straight forward in their intentions if this was the case. But, then, this is FDA. The answer is in the question.
Market Data 
Markets 
AI
